Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effects of Antifibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis [IPF_PBMC]

ABSTRACT: Two antifibrotic drugs, pirfenidone (PFD) and nintedanib (NTD), are currently used to treat idiopathic pulmonary fibrosis (IPF). Peripheral blood mononuclear cells are immunocompetent cells that can predispose to those within the lungs and orchestrate cell-cell interactions associated with IPF pathogenesis. We employed RNA sequencing to examine the transcriptome signature in bulk peripheral blood mononuclear cells of patients with IPF and the effects of antifibrotic drugs on these signatures. Differentially expressed genes (DEGs) were analyzed in patients with IPF and healthy controls, before and after antifibrotic treatment. Enrichment analysis suggested that fatty acid elongation interferes with profibrotic TGF-β/ signaling and production of oxidative stress since treatment with NTD upregulated the elongation enzymes ELOVL6 and ELOVL7. Treatment with PFD downregulated COL1A1 which produces wound-healing collagens, as activated monocyte-derived macrophages during tissue damage participate in the production of collagen, type I, and alpha 1. Plasminogen activator inhibitor-1 (PAI-1) regulates wound healing by inhibiting plasmin-mediated matrix metalloproteinases activation, and inhibition of PAI-1 activity attenuates lung fibrosis. DEGs analysis suggested that both PFD and NTD upregulated SERPINE1 which in turn regulates PAI-1 activity. This study detected different DEGs as a result of PFD and NTD treatments, suggesting different mechanistic roles for the two antifibrotic drugs.

ORGANISM(S): Homo sapiens

PROVIDER: GSE248485 | GEO | 2024/03/28

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Central Lung Gene Expression Associates with Myofibroblast Activity in Idiopathic Pulmonary Fibrosis

Project description:Non-fibrotic central regions of IPF lungs demonstrate massive dysregulated gene expression involving enhanced T-cell differentiation, pulmonary fibrosis idiopathic, and wound healing pathways. Enhancement of myofibroblast features without apparent extra-cellular matrix deposition in the central non-fibrotic region of IPF lungs renders a window for cell-based molecular targeting therapy.

2022-05-31 | GSE199949 | GEO

Metabolic Reprogramming and Reliance in Human Skin Wound Healing

Project description:Impaired skin wound healing is a significant global health issue, especially among the elderly. Wound healing is a well-orchestrated process involving the sequential phases of inflammation, proliferation, and tissue remodeling. Although wound healing is a highly dynamic and energy-requiring process, the role of metabolism remains largely unexplored. By combining transcriptomics and metabolomics of human skin biopsy samples, we mapped the core bioenergetic and metabolic changes in normal acute as well as chronic wounds in elderly subjects. We found upregulation of glycolysis, the tricarboxylic acid cycle, glutaminolysis, and β-oxidation in the later stages of acute wound healing and in chronic wounds. To ascertain the role of these metabolic pathways on wound healing, we targeted each pathway in a wound healing assay as well as in a human skin explant model using metabolic inhibitors and stimulants. Enhancement or inhibition of glycolysis and, to a lesser extent, glutaminolysis had a far greater impact on wound healing than similar manipulations of oxidative phosphorylation and fatty acid β-oxidation. These findings increase the understanding of wound metabolism and identify glycolysis and glutaminolysis as potential targets for therapeutic intervention.

2024-07-02 | MTBLS3315 | MetaboLights

Forkhead Box F1 (FOXF1) represses fibroblast functions relevant to fibrogenesis

Project description:Aberrant expression of master phenotype regulators by lung fibroblasts may play a central role in idiopathic pulmonary fibrosis (IPF). Interrogating IPF fibroblast transcriptome datasets, we identified Forkhead Box F1 (FOXF1), a DNA-binding protein required for lung development, as a candidate actor in IPF. Thus, we determined FOXF1 expression levels in fibroblasts cultured from normal or IPF lungs in vitro, and explored FOXF1 functions in these cells using transient and stable loss-of-function and gain-of-function models. FOXF1 mRNA and protein were expressed at higher levels in IPF compared with controls. In normal lung fibroblasts, FOXF1 repressed key fibroblast functions such as proliferation, survival, and expression of collagen-1 (COL1) and actin related protein 2/3 complex, subunit 2 (ARPC2). ARPC2 knockdown mimicked FOXF1 overexpression with regard to proliferation and COL1 expression. FOXF1 expression was induced by the antifibrotic mediator prostaglandin E2 (PGE2). Ex vivo, FOXF1 knockdown conferred CCL-210 lung fibroblasts the ability to implant and survive in uninjured mouse lungs. In IPF lung fibroblasts, FOXF1 regulated COL1 but not ARPC2 expression. In conclusion, FOXF1 functions and regulation were consistent with an antifibrotic role in lung fibroblasts. Higher FOXF1 levels in IPF fibroblasts may thus participate in a compensatory response to fibrogenesis. Lung fibroblasts derived from 4 different IPF patients (P313, P355, P375 and P426) were transiently transfected with pcfoxf1 or control pcDNA3.1-constructs. Total RNAs were extracted 24 h after transfection and hybridized on microarrays. One color experiment with 2 experimental conditions: pcfoxf1 and pcDNA3.1

2014-10-01 | E-GEOD-52612 | biostudies-arrayexpress

Mice livers: high fat diet versus high fat diet (HF) supplemented with pirfenidone (HFP)

Project description:Background & Aims: NASH is characterized by hepatic lipid accumulation and inflammation; and JMJD2B – a histone demethylase - upregulation has been linked to its progression. Pirfenidone is an antifibrotic agent with anti-inflammatory and antioxidant effects recognized to decrease NASH symptoms. Herein, our aim was to investigate PFD-induced epigenetics mechanisms involving JMJD2B and histone modifications in experimental NASH. Methods: Male C57BL/6J mice were fed with normo-diet, or high fat/carbohydrate diet (HF) for 16 weeks. A HF-subgroup was treated with PFD 300 mg/kg/d from week 8th to the end of protocol. Insulin tolerance test and liver and fat histological and biochemical analyses were carried out. Hepatic transcriptome was examined. Liver proteins were studied by western blot (WB) and Chromatin immunoprecipitation. In vitro, lipotoxicity was induced in HepG2 cells and proteins were evaluated using WB. Molecular docking was used to explore binding of PFD to JMJD2B. Results: Mice treated with PFD reduced weight gain, epididymal fat and inflammatory nodules, and steatosis in liver tissue, as well as, improved biochemical test. PFD modified the expression of Jmjd2b, Pparg, Fasn and Srebp1, and restored JMJD2B protein and H3K9me3 repressive mark, both in animal and cell models. PFD increased hepatic enrichment of H3K9me2 and H3K9me3 at the promoter region of Fasn and Srebp1, and Pparg. In HepG2 cells, PFD reduced lipid vacuole accumulation. In silico, PFD interacted with JMJD2B catalytic site. Conclusion: PFD is an epigenetic regulator modifying JMJD2B activity, resulting in reduced NASH traits.

2024-08-22 | GSE275069 | GEO

A role for the mitogen-activated protein kinase kinase kinase 1 in epithelial wound healing

Project description:The mitogen-activated protein kinase kinase (MEK) kinase 1 (MEKK1), also known as MAP3K1, mediates activin B (ActB) signals required for eyelid epithelium morphogenesis during mouse fetal development. The present study investigates the role of MEKK1 in epithelial wound healing, another activin-regulated biological process. In a skin wound model, injury markedly stimulates MEKK1 expression and activity, which are in turn required for the expression of genes involved in extracellular matrix (ECM) homeostasis. MEKK1 ablation or down-regulation by interfering RNA significantly delays skin wound closure and impairs activation of Jun NH2-terminal kinases, induction of plasminogen activator inhibitor (PAI)-1, and restoration of cell-cell junctions of the wounded epidermis. Conversely, expression of wild-type MEKK1 accelerates reepithelialization of full-thickness skin and corneal debridement wounds by mechanisms involving epithelial cell migration, a cell function that is partially abolished by neutralizing antibodies for PAI-1 and metalloproteinase III. Our data suggest that MEKK1 transmits wound signals, leading to the transcriptional activation of genes involved in ECM homeostasis, epithelial cell migration, and wound reepithelialization.

2022-07-13 | GSE201823 | GEO

Next Generation Sequencing Facilitates Analysis of Penfluridol Treatment and Control SamplesTranscriptomes

Project description:Endometrial cancer (EC) is the most common cancer of the female reproductive tract and one of the few cancers for which survival has not substantially improved since the mid-1970s, reflecting few advances in treatment. The main therapeutic method of EC is surgical therapy assisted with radiotherapy and chemotherapy at present. Progesterone is the first-line drug for conservative treatment, but it faces the challenge of drug resistance and is ineffective for type II EC. There is an urgent clinical need to find new therapeutic targets and candidate drugs. Repurposing of existing drugs is a good strategy to discover new candidate drugs. Herein, 33 antipsychotics in our drug library were screened and penfluridol (PFD) was found to exhibit excelent anti-EC activity. Then the molecular target of PFD was revealed as the GTP-binding protein Septin7 using activity-based protein profiling (ABPP) techniques. Septin7 functioned as a tumor suppressor in EC and PFD exhibited weaker anticancer properties in Septin7 knockdown EC cells, indicating that Septin7 is essential for PFD biological activity. Notably, our investigations of PFD mechanism suggested that PFD binding with Septin7 inhibited the interaction of Septin7 with microtubules, thereby inhibiting microtubule polymerization and arresting the cell cycle in G1 phase. In addition, RNA-seq analysis and western blot showed that PFD could induce cell apoptosis by regulating Septin7-PIK3CA-AKT-Caspase3 pathway. Finally, PFD displayed significant in vivo antitumor efficacy in KLE endometrial cancer xenograft models without causing obvious side effects. Taken together, our findings revealed new target and mechanistic insights in EC therapeutic strategy and offer a potential candidate for the treatment of EC, especially progesterone resistance EC.

2023-12-25 | GSE236228 | GEO

Synergy between plasminogen activator inhibitor-1 and Snail in tumoral migration

Project description:Snail, a family of transcriptional repressors implicated in cell movement, has been correlated with tumour invasivity. The Plasminogen Activation system (PAs), including urokinase (uPA), its receptor (uPAR), and its inhibitor (PAI-1), also plays a key role in cancer invasion and metastasis, either through proteolytic degradation or by non proteolytic modulation of cell adhesion and migration. Thus, Snail and PAs both influence those processes and are over-expressed in cancers. In this study we aimed to determine first whether Snail activity is correlated with PAs components expression and second how this correlation can influence tumoral cell migration. Keywords: Tumoral migration Comparison the invasive breast cancer cell-line MDA-MB-231 expressing Snail (MDA-Neo) with its derived clone expressing a dominant negative form of Snail (Snail-DN). Expression of PAs mRNAs was performed by cDNA microarrays and real time quantitative RT-PCR. Wound healing assay was used to determine cell migration. PAI-1â??s distribution was assessed by immunostaining.

2010-06-24 | E-GEOD-10395 | biostudies-arrayexpress

Epigenetic alterations underlie airway macrophage differentiation and phenotype during lung fibrosis

Project description:Airway macrophages (AMs) are key regulators of the lung environment and are implicated in the pathogenesis of idiopathic pulmonary fibrosis (IPF). However, the epigenetics of AMs development and influence of disease on these processes remain limited. Using EPIC arrays, we undertook DNA methylation profiling in AMs from Healthy (n=14) and IPF (n=30) donors. Deconvolution using reference myeloid-cell methylomes identified epigenetic heterogeneity was a key characteristic of both AMs and IPF and adjustment for myeloid methylome composition was critical in differential methylation analysis. We identified n=11 and n=49 differentially methylated positions (DMPs) and regions (DMRs) between healthy and IPF AMs respectively. Both DMPs and DMRs encompassed genes involved in lipid (LPCAT1) and glucose (PFKB3) metabolism and processes and pathways pertinent to macrophage biology (e.g. extravasations) and IPF pathogenesis (e.g. wound healing). These data identify that changes in the epigenome underpin the development and function of AMs in the IPF lung.

2021-10-04 | GSE159655 | GEO

Activation of Heat Shock Response Augments Fibroblast Growth Factor-1 Expression in Wounded Lung Epithelium: A Possible Mechanism for Progressive Lung Fibrosis

Project description:Human cells were resistant to apoptosis induced by TNFα and Heat Shock (HS). Wound healing in NHBE and A549 cells occurred 30-50% more rapidly when cells were exposed to HS immediately after wounding. Gene expression analysis showed that HS synergized with wounding to increase expression of FGF1 by 30-fold. Enhanced FGF1 expression was blocked by inhibitors of p38 MAP kinase (SB203580) and heat shock factor (HSF)-1 (KNK-437) and in HSF1 knockout BEAS2B cells. Accelerated wound closure was reduced by SB203580, KNK-437, and by SU-5402, an inhibitor of FGF receptors 1 and 3. FGF1 was expressed in A549 and BEAS2B from promoters C and D. Finally, we found that FGF1 and HSP70 mRNA levels were 7.5- and 5.9-fold higher in IPF than normal lung. Confocal immunofluorescent microscopy showed FGF1 and HSP70 to be co-localized in affected regions of IPF but not normal lung. Epithelial injury and HS synergize to activate expression of FGF1 in lung epithelium through mechanisms that include p38 MAP kinase and HSF1. FGF1 expression and heat shock pathway activation is increased and colocalizes to defined foci in IPF lung, suggesting this pathway may have an important impact on lung injury, healing, and fibrosis.

2017-09-08 | GSE83844 | GEO